John Szumowski is an Infectious Disease physician affiliated with University of California, San Francisco. OpenAlex indexes 28 publications with 1,241 citations (h-index 12).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
4150 Clement St
San Francisco, CA 941211563
Telephone
415-221-4810Provider last certified this registry record 12 Aug 2025.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
27.3%Statin9.2%Atorvastatin Calcium91%Pravastatin Sodium9%Part D<11 patientsBeta blocker4.5%Metoprolol Succinate73%Carvedilol27%Part D<11 patients+ 7 more classes in this area
Anti-infectives
23.1%Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor9.1%Tivicay52%Cabenuva23%Dovato10%Isentress9%Juluca6%Part D<11 patientsProtease Inhibitor3.2%Symtuza47%Prezcobix36%Ritonavir17%Part D<11 patients+ 6 more classes in this area
Nervous system
19.2%Gabapentinoids4.7%Gabapentin68%Pregabalin32%Part D<11 patientsSSRI3.6%Escitalopram Oxalate32%Trazodone Hcl31%Sertraline Hcl25%Paroxetine Hcl13%Part D<11 patients+ 9 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Prolonged Paradoxical TB-IRIS: 2 Case Reports and a Review of the Literature
Open Forum Infectious Diseases
2026 - Experience with Linezolid for the Treatment of Rifampin-Susceptible Tuberculosis in San Francisco
Open Forum Infectious Diseases
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Kristine Yaffe, MD
University of California, San Francisco
Peter Carroll, MD
University of California, San Francisco
Mitchel Berger, MD
University of California, San Francisco
Elyse Foster, MD
University of California, San Francisco
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”